Document and Entity Information
Document and Entity Information - shares | 4 Months Ended | |
Jun. 30, 2024 | Aug. 13, 2024 | |
Document Information [Line Items] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Jun. 30, 2024 | |
Document Transition Report | false | |
Entity File Number | 001-42134 | |
Entity Registrant Name | Melar Acquisition Corp. I/Cayman | |
Entity Incorporation, State or Country Code | E9 | |
Entity Tax Identification Number | 87-1634103 | |
Entity Address, Address Line One | 119 West 23rd Street | |
Entity Address, Adress Line Two | Suite 206 | |
Entity Address, City or Town | New York | |
Entity Address State Or Province | NY | |
Entity Address, Postal Zip Code | 10011 | |
City Area Code | 702 | |
Local Phone Number | 781-1120 | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | true | |
Entity Ex Transition Period | false | |
Entity Shell Company | true | |
Entity Central Index Key | 0002016221 | |
Current Fiscal Year End Date | --12-31 | |
Document Fiscal Year Focus | 2024 | |
Document Fiscal Period Focus | Q2 | |
Amendment Flag | false | |
Units, Each Consisting Of One ClassA Ordinary Share And One-Half Of One Redeemable Warrant [Member] | ||
Document Information [Line Items] | ||
Title of 12(b) Security | Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant | |
Trading Symbol | MACIU | |
Security Exchange Name | NASDAQ | |
Class A ordinary shares | ||
Document Information [Line Items] | ||
Title of 12(b) Security | Class A ordinary shares, par value $0.0001 per share | |
Trading Symbol | MACI | |
Security Exchange Name | NASDAQ | |
Entity Common Stock, Shares Outstanding | 16,000,000 | |
Warrants Each Whole Warrant Exercisable For One Share Of Class Ordinary Share At Exercise Price [Member] | ||
Document Information [Line Items] | ||
Title of 12(b) Security | Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share | |
Trading Symbol | MACIW | |
Security Exchange Name | NASDAQ | |
Class B ordinary shares | ||
Document Information [Line Items] | ||
Entity Common Stock, Shares Outstanding | 5,621,622 |
CONDENSED BALANCE SHEET
CONDENSED BALANCE SHEET | Jun. 30, 2024 USD ($) | |
Current assets | ||
Cash | $ 1,037,126 | |
Prepaid expenses | 23,732 | |
Prepaid insurance | 147,468 | |
Total Current Assets | 1,208,326 | |
Long-term prepaid insurance | 142,620 | |
Cash and marketable securities held in Trust Account | 160,167,532 | |
TOTAL ASSETS | 161,518,478 | |
Current liabilities | ||
Accounts payable | 16,084 | |
Due to Sponsor | $ 2,447 | |
Other Liability, Current, Related Party [Extensible Enumeration] | us-gaap:RelatedPartyMember | |
Over-allotment option liability | $ 141,754 | |
Total current liabilities | 160,285 | |
Deferred underwriting fee | 6,600,000 | |
Total Liabilities | 6,760,285 | |
Commitments and Contingencies (Note 6) | ||
Shareholders' deficit | ||
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued or outstanding | ||
Accumulated deficit | (5,409,945) | |
Total Shareholders' Deficit | (5,409,339) | |
TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT | 161,518,478 | |
Class A ordinary shares subject to possible redemption | ||
Current liabilities | ||
Class A ordinary shares subject to possible redemption, 16,000,000 shares at redemption value of $10.01 per share | 160,167,532 | |
Class B ordinary shares | ||
Shareholders' deficit | ||
Ordinary shares | $ 606 | [1] |
[1] This number includes up to 439,189 Class B ordinary shares subject to forfeiture if the remainder of the over-allotment option is not exercised by the underwriters within the 45-day over-allotment period (Note 7). Such 439,189 Class B ordinary shares were forfeited on July 24, 2024. |
CONDENSED BALANCE SHEET (Parent
CONDENSED BALANCE SHEET (Parenthetical) | Jun. 30, 2024 $ / shares shares |
Temporary equity shares outstanding | 16,000,000 |
Preference shares, par value (in dollars per share) | $ / shares | $ 0.0001 |
Preference shares, shares authorized | 5,000,000 |
Preference shares, share issued | 0 |
Preference shares, share outstanding | 0 |
Class A ordinary shares | |
Common shares, par value (in dollars per share) | $ / shares | $ 0.0001 |
Common shares, shares authorized | 500,000,000 |
Common shares shares issued | 0 |
Class A ordinary shares subject to possible redemption | |
Temporary equity shares outstanding | 16,000,000 |
Ordinary shares subject to possible redemption, par value (in Dollars per share) | $ / shares | $ 10.01 |
Common shares, shares outstanding | 16,000,000 |
Class A ordinary shares not subject to possible redemption | |
Common shares shares issued | 0 |
Common shares, shares outstanding | 0 |
Class B ordinary shares | |
Common shares, par value (in dollars per share) | $ / shares | $ 0.0001 |
Common shares, shares authorized | 50,000,000 |
Common shares shares issued | 6,060,811 |
Common shares, shares outstanding | 6,060,811 |
Number of shares subject to forfeiture | 439,189 |
CONDENSED STATEMENTS OF OPERATI
CONDENSED STATEMENTS OF OPERATIONS - USD ($) | 3 Months Ended | 4 Months Ended |
Jun. 30, 2024 | Jun. 30, 2024 | |
General and administrative costs | $ 88,594 | $ 107,729 |
Loss from operations | (88,594) | (107,729) |
Other income: | ||
Change in fair value of over-allotment option liability | 27,365 | 27,365 |
Interest earned on cash and marketable securities held in Trust Account | 167,532 | 167,532 |
Total other income | 194,897 | 194,897 |
Net income | $ 106,303 | $ 87,168 |
Class A ordinary shares subject to possible redemption | ||
Other income: | ||
Weighted average shares outstanding, Basic (in shares) | 1,777,778 | 1,441,441 |
Weighted average shares outstanding, Diluted (in shares) | 1,777,778 | 1,441,441 |
Basic net income per share (in dollars per share) | $ 0.01 | $ 0.01 |
Diluted net income per share (in dollars per share) | $ 0.01 | $ 0.01 |
Class B ordinary shares | ||
Other income: | ||
Weighted average shares outstanding, Basic (in shares) | 5,309,309 | 5,301,923 |
Weighted average shares outstanding, Diluted (in shares) | 5,621,622 | 5,505,550 |
Basic net income per share (in dollars per share) | $ 0.01 | $ 0.01 |
Diluted net income per share (in dollars per share) | $ 0.01 | $ 0.01 |
CONDENSED STATEMENT OF CHANGES
CONDENSED STATEMENT OF CHANGES IN SHAREHOLDERS' DEFICIT - USD ($) | Ordinary Shares Class A ordinary shares not subject to possible redemption | Ordinary Shares Class B ordinary shares | Additional Paid-in Capital Private Placement Warrants | Additional Paid-in Capital Public Warrants | Additional Paid-in Capital | Accumulated Deficit | Private Placement Warrants | Public Warrants | Total | ||
Beginning balance at Mar. 10, 2024 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | ||||||
Beginning balance (in shares) at Mar. 10, 2024 | 0 | 0 | [1] | ||||||||
Changes in shareholders' deficit | |||||||||||
Issuance of Class B ordinary shares to Sponsor | $ 606 | 24,394 | 25,000 | ||||||||
Issuance of Class B ordinary shares to Sponsor (in shares) | [1] | 6,060,811 | |||||||||
Net Income (Loss) | (19,135) | (19,135) | |||||||||
Ending balance at Mar. 31, 2024 | $ 606 | 24,394 | (19,135) | 5,865 | |||||||
Ending balance (in shares) at Mar. 31, 2024 | [1] | 6,060,811 | |||||||||
Beginning balance at Mar. 10, 2024 | $ 0 | $ 0 | 0 | 0 | 0 | ||||||
Beginning balance (in shares) at Mar. 10, 2024 | 0 | 0 | [1] | ||||||||
Changes in shareholders' deficit | |||||||||||
Net Income (Loss) | 87,168 | ||||||||||
Ending balance at Jun. 30, 2024 | $ 606 | (5,409,945) | (5,409,339) | ||||||||
Ending balance (in shares) at Jun. 30, 2024 | [1] | 6,060,811 | |||||||||
Beginning balance at Mar. 31, 2024 | $ 606 | 24,394 | (19,135) | 5,865 | |||||||
Beginning balance (in shares) at Mar. 31, 2024 | [1] | 6,060,811 | |||||||||
Changes in shareholders' deficit | |||||||||||
Accretion for Class A ordinary shares to redemption amount | (6,943,752) | (5,497,113) | (12,440,865) | ||||||||
Warrants issued | $ 5,000,000 | $ 2,080,000 | $ 5,000,000 | $ 2,080,000 | |||||||
Allocated value of transaction costs to Public and Private Warrants | $ (160,642) | (160,642) | |||||||||
Net Income (Loss) | 106,303 | 106,303 | |||||||||
Ending balance at Jun. 30, 2024 | $ 606 | $ (5,409,945) | $ (5,409,339) | ||||||||
Ending balance (in shares) at Jun. 30, 2024 | [1] | 6,060,811 | |||||||||
[1] Included an aggregate of 439,189 Class B ordinary shares subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters (see Note 7). Such 439,189 Class B ordinary shares were forfeited on July 24, 2024. |
CONDENSED STATEMENT OF CHANGE_2
CONDENSED STATEMENT OF CHANGES IN SHAREHOLDERS' DEFICIT (Parenthetical) | 3 Months Ended |
Jun. 30, 2024 shares | |
Class B ordinary shares | |
Number of shares subject to forfeiture | 439,189 |
Private Placement Warrants | |
Number of warrants sold | 5,000,000 |
CONDENSED STATEMENT OF CASH FLO
CONDENSED STATEMENT OF CASH FLOWS | 4 Months Ended |
Jun. 30, 2024 USD ($) | |
Cash Flows from Operating Activities: | |
Net income | $ 87,168 |
Adjustments to reconcile net income to net cash used in operating activities: | |
Formation costs paid by Sponsor in exchange for issuance of Class B ordinary shares | 6,236 |
Interest earned on cash and marketable securities held in Trust Account | (167,532) |
Payment of general and administrative costs through promissory note - related party | 10,420 |
Change in fair value of over-allotment option liability | (27,365) |
Changes in operating assets and liabilities: | |
Prepaid expenses | (313,820) |
Due from Sponsor | 2,447 |
Accounts payable | 16,084 |
Net cash used in operating activities | (386,362) |
Cash Flows from Investing Activities: | |
Investment of cash in Trust Account | (160,000,000) |
Net cash used in investing activities | (160,000,000) |
Cash Flows from Financing Activities: | |
Proceeds from sale of Units, net of underwriting discounts paid | 157,000,000 |
Proceeds from sale of Private Placements Warrants | 5,000,000 |
Repayment of promissory note - related party | (249,389) |
Payment of offering costs | (327,123) |
Net cash provided by financing activities | 161,423,488 |
Net Change in Cash | 1,037,126 |
Cash - End of period | 1,037,126 |
Non-Cash investing and financing activities: | |
Deferred offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares | 18,764 |
Deferred offering costs paid through promissory note - related party | 238,969 |
Overallotment liability at Initial Public Offering date | 169,119 |
Accretion of Class A ordinary shares to redemption value | 12,440,865 |
Deferred underwriting fee payable | 6,600,000 |
Offering costs charged to additional paid in capital | $ 584,856 |
DESCRIPTION OF ORGANIZATION AND
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS | 4 Months Ended |
Jun. 30, 2024 | |
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS | |
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS | NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Melar Acquisition Corp. I (the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on March 11, 2024. The Company was incorporated for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company has not selected any specific Business Combination target and the Company has not, nor has anyone on its behalf, engaged in any substantive discussions, directly or indirectly, with any Business Combination target with respect to an initial Business Combination with the Company. As of June 30, 2024, the Company had not commenced any operations. All activity for the period from March 11, 2024 (inception) through June 30, 2024 relates to the Company’s formation, its initial public offering, which is described below (“Initial Public Offering”), and subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year end. The registration statement for the Company’s Initial Public Offering was declared effective on June 17, 2024. On June 20, 2024, the Company consummated the Initial Public Offering of 16,000,000 units (the “Units”), which includes the partial exercise by the underwriters of their over-allotment option in the amount of 1,000,000 Units (Note 6), at $10.00 per Unit, generating gross proceeds of $160,000,000, which is discussed in Note 3. Each Unit consists of one Class A ordinary share and one Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 5,000,000 warrants (the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant, in a private placement to Melar Acquisition Sponsor I LLC, the Company’s sponsor (the “Sponsor”), and Cohen & Company Capital Markets, a division of J.V.B. Financial Group, LLC and Seaport Global Securities LLC, the representatives of the underwriters of the Initial Public Offering, generating gross proceeds of $5,000,000, which is described in Note 4. Transaction costs amounted to $10,184,856, consisting of $3,000,000 of cash underwriting fee, $6,600,000 of deferred underwriting fee (see additional discussion in Note 6), and $584,856 of other offering costs. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the Private Placement Warrants, although substantially all of the net proceeds are intended to be generally applied toward consummating a Business Combination (less deferred underwriting commissions). The Company’s Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the net balance in the Trust Account (as defined below) (excluding the amount of deferred underwriting discounts held and taxes payable on the income earned on the Trust Account) at the time of the signing of an agreement to enter into a Business Combination. However, the Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to successfully effect a Business Combination. Following the closing of the Initial Public Offering, on June 20, 2024, an amount of $160,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units and the sale of the Private Placement Warrants was placed in the trust account (the “Trust Account”), located in the United States, with Continental Stock Transfer & Trust Company acting as trustee, and held in cash, including in demand deposit accounts at a bank, or invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act, which invest only in direct U.S. government treasury obligations; the holding of these assets in this form is intended to be temporary and for the sole purpose of facilitating the intended Business Combination. To mitigate the risk that the Company might be deemed to be an investment company for purposes of the Investment Company Act, which risk increases the longer that it holds investments in the Trust Account, the Company may, at any time (based on the management team’s ongoing assessment of all factors related to the potential status under the Investment Company Act), instruct the trustee to liquidate the investments held in the Trust Account and instead to hold the funds in the Trust Account in cash or in an interest-bearing demand deposit account at a bank. Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company for taxes payable, the proceeds from the Initial Public Offering and the sale of the Private Placement Warrants will not be released from the Trust Account until the earliest of (i) the completion of the Company’s initial Business Combination, (ii) the redemption of the Company’s public shares if the Company is unable to complete the initial Business Combination within 24 months from the closing of the Initial Public Offering (i.e., June 20, 2026) or by such earlier liquidation date as the board of directors may approve (the “Completion Window”), subject to applicable law, or (iii) the redemption of the Company’s public shares properly submitted in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association to (A) modify the substance or timing of the Company’s obligation to allow redemption in connection with the initial Business Combination or to redeem 100% of the Company’s public shares if the Company has not consummated an initial Business Combination within the Completion Window or (B) with respect to any other material provisions relating to shareholders’ rights or pre-initial Business Combination activity. The proceeds deposited in the Trust Account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of the Company’s public shareholders. The Company will provide its public shareholders with the opportunity to redeem, regardless of whether they abstain, vote for, or against, the Company’s initial Business Combination, all or a portion of their public shares upon the completion of the initial Business Combination either (i) in connection with a general meeting called to approve the initial Business Combination or (ii) without a shareholder vote by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a proposed initial Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public shareholders will be entitled to redeem their shares at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account calculated as of two business days prior to the consummation of the initial Business Combination, including interest earned on the funds held in the Trust Account (less taxes payable), divided by the number of then outstanding public shares, subject to the limitations. The amount in the Trust Account was initially $10.00 per public share. The ordinary shares subject to redemption were recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity.” In such case, if the Company seeks shareholder approval, a majority of the issued and outstanding shares voted are voted in favor of the Business Combination. The Company will have only the duration of the Completion Window to complete the initial Business Combination. However, if the Company is unable to complete its initial Business Combination within the Completion Window, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter (and subject to lawfully available funds therefor), redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account (which interest shall be net of taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then-outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the board of directors, liquidate and dissolve, subject in each case to obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. The Sponsor, officers and directors entered into a letter agreement with the Company, pursuant to which they have agreed to (i) waive their redemption rights with respect to the Class B ordinary shares initially purchased by the Sponsor (the “founder shares”) and public shares in connection with the completion of the initial Business Combination; (ii) waive their redemption rights with respect to their founder shares and public shares in connection with a shareholder vote to approve an amendment to the Company’s amended and restated memorandum and articles of association (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the initial Business Combination or to redeem 100% of the public shares if the Company has not consummated an initial Business Combination within the Completion Window or (B) with respect to any other material provisions relating to shareholders’ rights or pre-initial Business Combination activity; (iii) waive their rights to liquidating distributions from the Trust Account with respect to their founder shares if the Company fails to complete the initial Business Combination within the Completion Window, although they will be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails to complete the initial Business Combination within the Completion Window and to liquidating distributions from assets outside the Trust Account; and (iv) vote any founder shares held by them and any public shares purchased during or after the Initial Public Offering (including in open market and privately negotiated transactions) in favor of the initial Business Combination. The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and the Company believes that the Sponsor’s only assets are securities of the Company. Therefore, the Company cannot assure that the Sponsor would be able to satisfy those obligations. |
SUMMARY OF SIGNIFICANT ACCOUNTI
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | 4 Months Ended |
Jun. 30, 2024 | |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of Securities and Exchange Commission (the “SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s prospectus for its Initial Public Offering as filed with the SEC on June 18, 2024, as well as the Company’s Current Report on Form 8-K, as filed with the SEC on June 20, 2024. The interim results for the three months ended June 30, 2024 and for the period from March 11, 2024 (inception) through June 30, 2024 are not necessarily indicative of the results to be expected for the year ending December 31, 2024 or for any future periods. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of the condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $1,037,126 in cash and no cash equivalents as of June 30, 2024. Cash and Marketable Securities Held in Trust Account At June 30, 2024, substantially all of the assets held in the Trust Account were held in U.S. Treasury Bills. The Company accounts for its marketable securities as trading securities under ASC 320, “Investments—Debt and Equity Securities,” where securities are presented at fair value on the condensed balance sheets. Gains and losses resulting from the change in fair value of marketable securities held in the Trust Account are included in interest earned on marketable securities held in Trust Account in the condensed statements of operations. For the three months ended June 30, 2024, the Company did not withdraw any interest earned on the Trust Account. Offering Costs The Company complies with the requirements of the ASC 340-10-S99 and SEC Staff Accounting Bulletin Topic 5A, ”Expenses of Offering.” Offering costs consist principally of professional and registration fees that are related to the Initial Public Offering. FASB ASC 470-20, “Debt with Conversion and Other Options,” addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. The Company applies this guidance to allocate Initial Public Offering proceeds from the Units between Class A ordinary shares and warrants, using the residual method by allocating Initial Public Offering proceeds first to assigned value of the warrants and then to the Class A ordinary shares. Offering costs allocated to the Class A ordinary shares were charged to temporary equity and offering costs allocated to the Public Warrants and Private Placement Warrants were charged to shareholders’ deficit as Public Warrants and Private Placement Warrants after management’s evaluation were accounted for under equity treatment. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the condensed balance sheet, primarily due to its short-term nature. Net Income per Ordinary Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. This presentation assumes an initial Business Combination as the most likely outcome. Net income per ordinary share is calculated by dividing the net income by the weighted average shares of ordinary shares outstanding for the respective period. The calculation of diluted net income does not consider the effect of the Public Warrants underlying the Units sold in the Initial Public Offering and the Private Placement Warrants to purchase an aggregate of 5,000,000 Class A ordinary shares in the calculation of diluted income per ordinary share, because their exercise is contingent upon future events. Accretion associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value. The following table presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for each class of ordinary shares: For the Period from March 11, 2024 (inception) For the Three Months Ended Through June 30, 2024 June 30, 2024 Class A Class B Class A Class B Basic net income per ordinary share: Numerator: Allocation of net income, basic $ 26,666 $ 79,637 $ 18,633 $ 68,535 Denominator: Basic weighted average ordinary shares outstanding 1,777,778 5,309,309 1,441,441 5,301,923 Basic net income per ordinary share $ 0.01 $ 0.01 $ 0.01 $ 0.01 For the Period from March 11, 2024 (inception) For the Three Months Ended Through June 30, 2024 June 30, 2024 Class A Class B Class A Class B Diluted net income per ordinary share: Numerator: Allocation of net income, diluted $ 25,540 $ 80,763 $ 18,087 $ 69,081 Denominator: Diluted weighted average ordinary shares outstanding 1,777,778 5,621,622 1,441,441 5,505,550 Diluted net income per ordinary share $ 0.01 $ 0.01 $ 0.01 $ 0.01 Income Taxes The Company accounts for income taxes under ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of June 30, 2024, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows. Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging.” For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statement of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. The underwriters’ over-allotment option is deemed to be a freestanding financial instrument indexed on the contingently redeemable shares and is accounted for as a liability pursuant to ASC 480. Warrant Instruments The Company accounted for the Public Warrants and Private Placement Warrants issued in connection with the Initial Public Offering and the private placement in accordance with the guidance contained in FASB ASC Topic 815, “Derivatives and Hedging.” Accordingly, the Company evaluated and classified the warrant instruments under equity treatment at their assigned values. Class A Redeemable Share Classification The public shares contain a redemption feature which allows for the redemption of such public shares in connection with the Company’s liquidation, or if there is a shareholder vote or tender offer in connection with the Company’s initial Business Combination. In accordance with ASC 480-10-S99, the Company classifies public shares subject to redemption outside of permanent deficit as the redemption provisions are not solely within the control of the Company. The Company recognizes changes in redemption value immediately as it occurs and will adjust the carrying value of redeemable shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable shares will result in charges against additional paid-in capital (to the extent available) and accumulated deficit. Accordingly, at June 30, 2024, Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ deficit section of the Company’s condensed balance sheet. At June 30, 2024, the Class A ordinary shares subject to redemption reflected in the condensed balance sheet are reconciled in the following table: Shares Amount Gross proceeds 16,000,000 $ 160,000,000 Less: Proceeds allocated to Public Warrants — (2,080,000) Proceeds allocated to the over-allotment option — (169,119) Class A ordinary shares issuance costs — (10,024,214) Plus: Accretion of carrying value to redemption value — 12,440,865 Class A ordinary shares subject to possible redemption, June 30, 2024 16,000,000 $ 160,167,532 Recent Accounting Pronouncements Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed financial statements. |
PUBLIC OFFERING
PUBLIC OFFERING | 4 Months Ended |
Jun. 30, 2024 | |
PUBLIC OFFERING | |
PUBLIC OFFERING | NOTE 3. PUBLIC OFFERING Pursuant to the Initial Public Offering, the Company sold 16,000,000 Units, which includes a partial exercise by the underwriters of their over-allotment option in the amount of 1,000,000 Units, at a price of $10.00 per Unit. Each Unit consists of one Class A ordinary share and one Warrants — The Company will not be obligated to deliver any Class A ordinary shares pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the Class A ordinary shares underlying the warrants is then effective and a prospectus relating thereto is current. No warrant will be exercisable and the Company will not be obligated to issue a Class A ordinary share upon exercise of a warrant unless the Class A ordinary share issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. In the event that the conditions in the two immediately preceding sentences are not satisfied with respect to a warrant, the holder of such warrant will not be entitled to exercise such warrant and such warrant may have no value and expire worthless. In no event will the Company be required to net cash settle any warrant. In the event that a registration statement is not effective for the exercised warrants, the purchaser of a Unit containing such warrant will have paid the full purchase price for the Unit solely for the Class A ordinary share underlying such Unit. Under the terms of the warrant agreement, the Company has agreed that, as soon as practicable, but in no event later than 20 60 If the holders exercise their Public Warrants on a cashless basis, they would pay the warrant exercise price by surrendering the warrants for that number of Class A ordinary shares equal to the quotient obtained by dividing (x) the product of the number of Class A ordinary shares underlying the warrants, multiplied by the excess of the “fair market value” of the Class A ordinary shares over the exercise price of the warrants by (y) the fair market value. The “fair market value” is the average reported closing price of the Class A ordinary shares for the 10 Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00 ● in whole and not in part; ● at a price of $0.01 per warrant; upon a minimum of 30 days’ prior written notice of redemption (the “ 30-day redemption period”); and ● if, and only if, the closing price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant) for any 20 trading days within a 30 - trading day period commencing at least 30 days after completion of the initial Business Combination and ending three business days before the Company sends the notice of redemption to the warrant holders. Additionally, if the number of outstanding Class A ordinary shares is increased by a share capitalization payable in Class A ordinary shares, or by a subdivision of ordinary shares or other similar event, then, on the effective date of such share capitalization, subdivision or similar event, the number of Class A ordinary shares issuable on exercise of each warrant will be increased in proportion to such increase in the outstanding ordinary shares. A rights offering made to all or substantially all holders of ordinary shares entitling holders to purchase Class A ordinary shares at a price less than the fair market value will be deemed a share capitalization of a number of Class A ordinary shares equal to the product of (i) the number of Class A ordinary shares actually sold in such rights offering (or issuable under any other equity securities sold in such rights offering that are convertible into or exercisable for Class A ordinary shares) and (ii) the quotient of (x) the price per Class A ordinary share paid in such rights offering and (y) the fair market value. For these purposes (i) if the rights offering is for securities convertible into or exercisable for Class A ordinary shares, in determining the price payable for Class A ordinary shares, there will be taken into account any consideration received for such rights, as well as any additional amount payable upon exercise or conversion, and (ii) fair market value means the volume weighted average price of Class A ordinary shares as reported during the ten ( 10 |
PRIVATE PLACEMENT
PRIVATE PLACEMENT | 4 Months Ended |
Jun. 30, 2024 | |
PRIVATE PLACEMENT | |
PRIVATE PLACEMENT | NOTE 4. PRIVATE PLACEMENT Simultaneously with the closing of the Initial Public Offering, the Sponsor and the underwriters purchased an aggregate of 5,000,000 Private Placement Warrants, at a price of $1.00 per Private Placement Warrant, or $5,000,000 in the aggregate, in a private placement. Each whole warrant entitles the registered holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment. The Private Placement Warrants are identical to the Public Warrants sold in the Initial Public Offering except that, so long as they are held by the Sponsor, the underwriters, or their permitted transferees, the Private Placement Warrants (i) may not (including the Class A ordinary shares issuable upon exercise of these Private Placement Warrants), subject to certain limited exceptions, be transferred, assigned or sold by the holders until 30 days after the completion of the initial Business Combination, (ii) will be entitled to registration rights and (iii) with respect to Private Placement Warrants held by the underwriters and/or their designees, will not be exercisable more than five years from the commencement of sales in the Initial Public Offering in accordance with Financial Industry Regulatory Authority Rule 5110(g)(8). The Sponsor, officers and directors have entered into a letter agreement with the Company, pursuant to which they have agreed to (i) waive their redemption rights with respect to their founder shares and public shares in connection with the completion of the initial Business Combination; (ii) waive their redemption rights with respect to their founder shares and public shares in connection with a shareholder vote to approve an amendment to the Company’s amended and restated memorandum and articles of association (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the initial Business Combination or to redeem 100% of the public shares if the Company has not consummated an initial Business Combination within the Completion Window or (B) with respect to any other material provisions relating to shareholders’ rights or pre-initial Business Combination activity; (iii) waive their rights to liquidating distributions from the Trust Account with respect to their founder shares if the Company fails to complete the initial Business Combination within the Completion Window, although they will be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails to complete the initial Business Combination within the Completion Window and to liquidating distributions from assets outside the Trust Account; and (iv) vote any founder shares held by them and any public shares purchased during or after the Initial Public Offering (including in open market and privately negotiated transactions) in favor of the initial Business Combination. |
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS | 4 Months Ended |
Jun. 30, 2024 | |
RELATED PARTY TRANSACTIONS | |
RELATED PARTY TRANSACTIONS | NOTE 5. RELATED PARTY TRANSACTIONS Founder Shares On March 11, 2024, the Sponsor made a capital contribution of $25,000, or approximately $0.004 per share, to cover certain of the Company’s expenses, for which the Company issued 6,060,811 founders shares to the Sponsor. The founder shares included an aggregate of up to 790,541 shares subject to forfeiture to the extent that the underwriters’ over-allotment option is not exercised in full, so that the number of founder shares would represent 26.0% of the Company’s issued and outstanding shares after the Initial Public Offering. On July 24, 2024, 439,189 founder shares were forfeited by the Sponsor. The Company’s initial shareholders have agreed not to transfer, assign or sell any of their founder shares and any Class A ordinary shares issued upon conversion thereof until the earlier to occur of (i) one year after the completion of the initial Business Combination or (ii) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction after the initial Business Combination that results in all of the Company’s shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property. Any permitted transferees will be subject to the same restrictions and other agreements of the Company’s initial shareholders with respect to any founder shares (the “Lock-up”). Notwithstanding the foregoing, if (1) the closing price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 30 Promissory Note — Related Party The Sponsor agreed to loan the Company an aggregate of up to $300,000 to be used for a portion of the expenses of the Initial Public Offering. The loan was non-interest bearing, unsecured and due at the earlier of December 31, 2024 or the closing of the Initial Public Offering. The outstanding balance of $249,389 was repaid at the closing of the Initial Public Offering on June 20, 2024 with an excess of $887 repaid to the Sponsor. At June 30, 2024, the excess of $887 is netted on the condensed balance sheet as a component of due to the Sponsor. Administrative Services Agreement The Company entered into an agreement with an affiliate of the Sponsor to pay an aggregate of $10,000 per month for office space, utilities, and secretarial and administrative support services commencing on the date the securities of the Company are first listed on the Nasdaq Global Market through the earlier of the Company’s consummation of a Business Combination and its liquidation. As of June 30, 2024, the Company accrued $3,333 for these services and reported this amount as a component of due to the Sponsor on the condensed balance sheet. For the three months ended June 30, 2024 and for the period from March 11, 2024 (inception) through June 30, 2024, the Company incurred $3,333 in fees for these services, which amount is included in the accompanying condensed statement of operations. Related Party Loans In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans. In the event that a Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay the Working Capital Loans but no proceeds from the Trust Account would be used to repay the Working Capital Loans. Up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.00 per warrant at the option of the lender. The warrants would be identical to the Private Placement Warrants. As of June 30, 2024, no Working Capital Loans were outstanding. |
COMMITMENTS
COMMITMENTS | 4 Months Ended |
Jun. 30, 2024 | |
COMMITMENTS | |
COMMITMENTS | NOTE 6. COMMITMENTS Risks and Uncertainties United States and global markets are experiencing volatility and disruption following the geopolitical instability resulting from the ongoing Russia-Ukraine conflict and the recent escalation of conflict in the Middle East and Southwest Asia. In response to the ongoing Russia-Ukraine conflict, the North Atlantic Treaty Organization (“NATO”) deployed additional military forces to eastern Europe, and the United States, the United Kingdom, the European Union and other countries have announced various sanctions and restrictive actions against Russia, Belarus and related individuals and entities, including the removal of certain financial institutions from the Society for Worldwide Interbank Financial Telecommunication (SWIFT) payment system. Certain countries, including the United States, have also provided and may continue to provide military aid or other assistance to Ukraine and to Israel, or have undertaken or will undertake military strikes in Southwest Asia, increasing geopolitical tensions among a number of nations. The invasion of Ukraine by Russia and the escalation of conflict in the Middle East and Southwest Asia and the resulting measures that have been taken, and could be taken in the future, by NATO, the United States, the United Kingdom, the European Union, Israel and its neighboring states and other countries have created global security concerns that could have a lasting impact on regional and global economies. Although the length and impact of the ongoing conflicts are highly unpredictable, they could lead to market disruptions, including significant volatility in commodity prices, credit and capital markets, as well as supply chain interruptions and increased cyber-attacks against U.S. companies. Additionally, any resulting sanctions could adversely affect the global economy and financial markets and lead to instability and lack of liquidity in capital markets. Any of the above-mentioned factors, or any other negative impact on the global economy, capital markets or other geopolitical conditions resulting from the Russian invasion of Ukraine, the escalation of conflict in the Middle East and Southwest Asia and subsequent sanctions or related actions, could adversely affect the Company’s search for an initial Business Combination and any target business with which the Company may ultimately consummate an initial Business Combination. Registration Rights The holders of the founder shares, Private Placement Warrants and the Class A ordinary shares underlying such Private Placement Warrants and warrants that may be issued upon conversion of the Working Capital Loans will have registration rights to require the Company to register a sale of any of the Company’s securities held by them and any other securities of the Company acquired by them prior to the consummation of the initial Business Combination pursuant to a registration rights agreement signed on the effective date of the Initial Public Offering. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain piggy-back registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The underwriters had a 45-day option from the date of the Initial Public Offering to purchase up to an additional 2,250,000 Units to cover over-allotments, if any. On June 20, 2024, simultaneously with the closing of the Initial Public Offering, the underwriters partially exercised the over-allotment option to purchase an additional 1,000,000 Units. The underwriters had 45 days from the date of the prospectus for the Initial Public Offering to purchase the remaining 1,250,000 Units. On August 4, 2024, the underwriters’ remaining over-allotment option expired worthless. The underwriters were entitled to an underwriting discount of $0.20 per Unit, or $3,000,000 in the aggregate, paid upon the closing of the Initial Public Offering. In addition, the underwriters were entitled to a deferred fee of $0.40 per Unit on Units other than those sold pursuant to the underwriters’ option to purchase additional Units, and $0.60 per Unit on Units sold pursuant to the underwriters’ over-allotment option or $6,600,000 in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely on amounts remaining in the Trust Account following all properly submitted shareholder redemption in connection with the consummation of the initial Business Combination. |
STOCKHOLDERS' DEFICIT
STOCKHOLDERS' DEFICIT | 4 Months Ended |
Jun. 30, 2024 | |
STOCKHOLDERS' DEFICIT | |
STOCKHOLDERS' DEFICIT | NOTE 7. STOCKHOLDERS’ DEFICIT Preference Shares outstanding Class A Ordinary Shares — Class B Ordinary Shares — outstanding The founder shares will automatically convert into Class A ordinary shares concurrently with or immediately following the consummation of the initial Business Combination or earlier at the option of the holder on a one-for-one basis, subject to adjustment for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like, and subject to further adjustment. In the case that additional Class A ordinary shares, or any other equity-linked securities, are issued or deemed issued in excess of the amounts sold in the Initial Public Offering and related to or in connection with the closing of the initial Business Combination, the ratio at which Class B ordinary shares convert into Class A ordinary shares will be adjusted (unless the holders of a majority of the outstanding Class B ordinary shares agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of Class A ordinary shares issuable upon conversion of all Class B ordinary shares will equal, in the aggregate, 26% of the sum of (i) the total number of all Class A ordinary shares outstanding upon the completion of the Initial Public Offering (including any Class A ordinary shares issued pursuant to the underwriters’ over-allotment option and excluding the Class A ordinary shares underlying the Private Placement Warrants issued to the Sponsor and the underwriters), plus (ii) all Class A ordinary shares and equity-linked securities issued or deemed issued, in connection with the closing of the initial Business Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in the initial Business Combination and any private placement-equivalent warrants issued to the Sponsor or any of its affiliates or to officers or directors upon conversion of Working Capital Loans) minus (iii) any redemptions of Class A ordinary shares by public shareholders in connection with an initial Business Combination; provided that such conversion of founder shares will never occur on a less than one-for-one basis. Holders of record of the Company’s Class A ordinary shares and Class B ordinary shares are entitled to one vote two-thirds if approved by a special resolution passed by the affirmative vote of at least 90% (or, where such amendment is proposed in respect of the consummation of the initial Business Combination, two-thirds) of the votes cast by such shareholders as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at the applicable general meeting of the Company. |
FAIR VALUE MEASUREMENTS
FAIR VALUE MEASUREMENTS | 4 Months Ended |
Jun. 30, 2024 | |
FAIR VALUE MEASUREMENTS | |
FAIR VALUE MEASUREMENTS | NOTE 8. FAIR VALUE MEASUREMENTS The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. The following table presents information about the Company’s assets that are measured at fair value on June 30, 2024 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value. Level June 30, 2024 Assets: U.S. Treasury Securities (Mature on 12/19/2024) 1 $ 160,167,532 Liabilities: Over-allotment option liability 3 $ 141,754 The over-allotment option was accounted for as a liability in accordance with ASC 815-40 and was presented within liabilities on the condensed balance sheet. The over-allotment option liability is measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of over-allotment option liability in the condensed statement of operations. On August 4, 2024, the underwriters’ remaining over-allotment option expired worthless. The Company used a Black-Scholes model to value the over-allotment option. The over-allotment option liability was classified within Level 3 of the fair value hierarchy at the measurement date due to the use of unobservable inputs inherent in pricing models are assumptions related to expected share-price volatility, expected life and risk-free interest rate. The Company estimates the volatility of its ordinary share based on historical volatility that matches the expected remaining life of the option. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the option. The expected life of the option is assumed to be equivalent to their remaining contractual term. The key inputs into the Black-Scholes model were as follows at initial measurement of the over-allotment option: June 30, Input 2024 Risk-free interest rate 5.47 % Expected term (years) 0.12 Expected volatility 5.42 % Exercise price $ 10.00 Fair value of over-allotment Unit $ 10.00 The following table provides a summary of the changes in the fair value of the Company’s Level 3 financial instruments that are measured at fair value on a recurring basis: Over-allotment option liability Fair value at March 11, 2024 (inception) $ — Initial measurement of over-allotment option liability at June 30, 2024 141,754 Fair value of over-allotment option liability at June 30, 2024 $ 141,754 Upon consummating the Initial Public Offering, June 20, 2024, the Public Warrants were valued using a binomial/lattice model that assumes optimal exercise of the Company’s redemption option, at the earliest possible date. The Public Warrants were valued using Level 3 inputs and have been classified within shareholders’ deficit and will not require remeasurement after issuance. The following table presents the quantitative information regarding market assumptions used in the valuation of the Public Warrants: June 20, Input 2024 Asset price $ 9.89 Term (years) 5.5 Risk-free rate 4.3 % Dividend yield $ 0.0 % Volatility $ 4.0 % Probability of closing 30.0 % |
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS | 4 Months Ended |
Jun. 30, 2024 | |
SUBSEQUENT EVENTS | |
SUBSEQUENT EVENTS | NOTE 9. SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the condensed balance sheet date up to the date that the condensed financial statements were issued. Based upon this review, other than as described below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed financial statements. Commencing on July 17, 2024, the holders of the Units issued in its Initial Public Offering may elect to separately trade the Class A ordinary shares and the Public Warrants included in the Units. Any Units not separated will continue to trade on the Nasdaq Global Market under the symbol “MACIU.” The Class A ordinary shares and the Public Warrants trade on the Nasdaq Global Market under the symbols “MACI” and “MACIW,” respectively. On July 24, 2024, 439,189 founder shares were forfeited by the Sponsor and as a result, there are 5,621,622 Class B ordinary shares issued and outstanding. |
Pay vs Performance Disclosure
Pay vs Performance Disclosure - USD ($) | 1 Months Ended | 3 Months Ended | 4 Months Ended |
Mar. 31, 2024 | Jun. 30, 2024 | Jun. 30, 2024 | |
Pay vs Performance Disclosure | |||
Net Income (Loss) | $ (19,135) | $ 106,303 | $ 87,168 |
Insider Trading Arrangements
Insider Trading Arrangements | 3 Months Ended |
Jun. 30, 2024 | |
Trading Arrangements, by Individual | |
Rule 10b5-1 Arrangement Adopted | false |
Non-Rule 10b5-1 Arrangement Adopted | false |
Rule 10b5-1 Arrangement Terminated | false |
Non-Rule 10b5-1 Arrangement Terminated | false |
SUMMARY OF SIGNIFICANT ACCOUN_2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) | 4 Months Ended |
Jun. 30, 2024 | |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | |
Basis of Presentation | Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of Securities and Exchange Commission (the “SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s prospectus for its Initial Public Offering as filed with the SEC on June 18, 2024, as well as the Company’s Current Report on Form 8-K, as filed with the SEC on June 20, 2024. The interim results for the three months ended June 30, 2024 and for the period from March 11, 2024 (inception) through June 30, 2024 are not necessarily indicative of the results to be expected for the year ending December 31, 2024 or for any future periods. |
Emerging Growth Company | Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. |
Use of Estimates | Use of Estimates The preparation of the condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. |
Cash and Cash Equivalents | Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $1,037,126 in cash and no cash equivalents as of June 30, 2024. |
Cash and Marketable Securities Held in Trust Account | Cash and Marketable Securities Held in Trust Account At June 30, 2024, substantially all of the assets held in the Trust Account were held in U.S. Treasury Bills. The Company accounts for its marketable securities as trading securities under ASC 320, “Investments—Debt and Equity Securities,” where securities are presented at fair value on the condensed balance sheets. Gains and losses resulting from the change in fair value of marketable securities held in the Trust Account are included in interest earned on marketable securities held in Trust Account in the condensed statements of operations. For the three months ended June 30, 2024, the Company did not withdraw any interest earned on the Trust Account. |
Offering Costs | Offering Costs The Company complies with the requirements of the ASC 340-10-S99 and SEC Staff Accounting Bulletin Topic 5A, ”Expenses of Offering.” Offering costs consist principally of professional and registration fees that are related to the Initial Public Offering. FASB ASC 470-20, “Debt with Conversion and Other Options,” addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. The Company applies this guidance to allocate Initial Public Offering proceeds from the Units between Class A ordinary shares and warrants, using the residual method by allocating Initial Public Offering proceeds first to assigned value of the warrants and then to the Class A ordinary shares. Offering costs allocated to the Class A ordinary shares were charged to temporary equity and offering costs allocated to the Public Warrants and Private Placement Warrants were charged to shareholders’ deficit as Public Warrants and Private Placement Warrants after management’s evaluation were accounted for under equity treatment. |
Fair Value of Financial Instruments | Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the condensed balance sheet, primarily due to its short-term nature. |
Net Income per Ordinary Share | Net Income per Ordinary Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. This presentation assumes an initial Business Combination as the most likely outcome. Net income per ordinary share is calculated by dividing the net income by the weighted average shares of ordinary shares outstanding for the respective period. The calculation of diluted net income does not consider the effect of the Public Warrants underlying the Units sold in the Initial Public Offering and the Private Placement Warrants to purchase an aggregate of 5,000,000 Class A ordinary shares in the calculation of diluted income per ordinary share, because their exercise is contingent upon future events. Accretion associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value. The following table presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for each class of ordinary shares: For the Period from March 11, 2024 (inception) For the Three Months Ended Through June 30, 2024 June 30, 2024 Class A Class B Class A Class B Basic net income per ordinary share: Numerator: Allocation of net income, basic $ 26,666 $ 79,637 $ 18,633 $ 68,535 Denominator: Basic weighted average ordinary shares outstanding 1,777,778 5,309,309 1,441,441 5,301,923 Basic net income per ordinary share $ 0.01 $ 0.01 $ 0.01 $ 0.01 For the Period from March 11, 2024 (inception) For the Three Months Ended Through June 30, 2024 June 30, 2024 Class A Class B Class A Class B Diluted net income per ordinary share: Numerator: Allocation of net income, diluted $ 25,540 $ 80,763 $ 18,087 $ 69,081 Denominator: Diluted weighted average ordinary shares outstanding 1,777,778 5,621,622 1,441,441 5,505,550 Diluted net income per ordinary share $ 0.01 $ 0.01 $ 0.01 $ 0.01 |
Income Taxes | Income Taxes The Company accounts for income taxes under ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of June 30, 2024, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. |
Concentration of Credit Risk | Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows. |
Derivative Financial Instruments | Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging.” For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statement of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. The underwriters’ over-allotment option is deemed to be a freestanding financial instrument indexed on the contingently redeemable shares and is accounted for as a liability pursuant to ASC 480. |
Warrant Instruments | Warrant Instruments The Company accounted for the Public Warrants and Private Placement Warrants issued in connection with the Initial Public Offering and the private placement in accordance with the guidance contained in FASB ASC Topic 815, “Derivatives and Hedging.” Accordingly, the Company evaluated and classified the warrant instruments under equity treatment at their assigned values. |
Class A Redeemable Share Classification | Class A Redeemable Share Classification The public shares contain a redemption feature which allows for the redemption of such public shares in connection with the Company’s liquidation, or if there is a shareholder vote or tender offer in connection with the Company’s initial Business Combination. In accordance with ASC 480-10-S99, the Company classifies public shares subject to redemption outside of permanent deficit as the redemption provisions are not solely within the control of the Company. The Company recognizes changes in redemption value immediately as it occurs and will adjust the carrying value of redeemable shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable shares will result in charges against additional paid-in capital (to the extent available) and accumulated deficit. Accordingly, at June 30, 2024, Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ deficit section of the Company’s condensed balance sheet. At June 30, 2024, the Class A ordinary shares subject to redemption reflected in the condensed balance sheet are reconciled in the following table: Shares Amount Gross proceeds 16,000,000 $ 160,000,000 Less: Proceeds allocated to Public Warrants — (2,080,000) Proceeds allocated to the over-allotment option — (169,119) Class A ordinary shares issuance costs — (10,024,214) Plus: Accretion of carrying value to redemption value — 12,440,865 Class A ordinary shares subject to possible redemption, June 30, 2024 16,000,000 $ 160,167,532 |
Recent Accounting Pronouncements | Recent Accounting Pronouncements Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed financial statements. |
SUMMARY OF SIGNIFICANT ACCOUN_3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) | 4 Months Ended |
Jun. 30, 2024 | |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | |
Schedule of computation of basic and diluted net loss per share | For the Period from March 11, 2024 (inception) For the Three Months Ended Through June 30, 2024 June 30, 2024 Class A Class B Class A Class B Basic net income per ordinary share: Numerator: Allocation of net income, basic $ 26,666 $ 79,637 $ 18,633 $ 68,535 Denominator: Basic weighted average ordinary shares outstanding 1,777,778 5,309,309 1,441,441 5,301,923 Basic net income per ordinary share $ 0.01 $ 0.01 $ 0.01 $ 0.01 For the Period from March 11, 2024 (inception) For the Three Months Ended Through June 30, 2024 June 30, 2024 Class A Class B Class A Class B Diluted net income per ordinary share: Numerator: Allocation of net income, diluted $ 25,540 $ 80,763 $ 18,087 $ 69,081 Denominator: Diluted weighted average ordinary shares outstanding 1,777,778 5,621,622 1,441,441 5,505,550 Diluted net income per ordinary share $ 0.01 $ 0.01 $ 0.01 $ 0.01 |
Schedule of reconciliation of Class A ordinary shares subject to redemption | Shares Amount Gross proceeds 16,000,000 $ 160,000,000 Less: Proceeds allocated to Public Warrants — (2,080,000) Proceeds allocated to the over-allotment option — (169,119) Class A ordinary shares issuance costs — (10,024,214) Plus: Accretion of carrying value to redemption value — 12,440,865 Class A ordinary shares subject to possible redemption, June 30, 2024 16,000,000 $ 160,167,532 |
FAIR VALUE MEASUREMENTS (Tables
FAIR VALUE MEASUREMENTS (Tables) | 4 Months Ended |
Jun. 30, 2024 | |
FAIR VALUE MEASUREMENTS | |
Schedule of company's assets and liabilities measured at fair value | Level June 30, 2024 Assets: U.S. Treasury Securities (Mature on 12/19/2024) 1 $ 160,167,532 Liabilities: Over-allotment option liability 3 $ 141,754 |
Schedule of changes in fair value of level 3 financial instruments measured on a recurring basis | Over-allotment option liability Fair value at March 11, 2024 (inception) $ — Initial measurement of over-allotment option liability at June 30, 2024 141,754 Fair value of over-allotment option liability at June 30, 2024 $ 141,754 |
Public Warrants | |
FAIR VALUE MEASUREMENTS | |
Schedule of measurement inputs for initial measurement | June 20, Input 2024 Asset price $ 9.89 Term (years) 5.5 Risk-free rate 4.3 % Dividend yield $ 0.0 % Volatility $ 4.0 % Probability of closing 30.0 % |
Over-allotment option | |
FAIR VALUE MEASUREMENTS | |
Schedule of measurement inputs for initial measurement | June 30, Input 2024 Risk-free interest rate 5.47 % Expected term (years) 0.12 Expected volatility 5.42 % Exercise price $ 10.00 Fair value of over-allotment Unit $ 10.00 |
DESCRIPTION OF ORGANIZATION A_2
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details) - USD ($) | 4 Months Ended | |
Jun. 20, 2024 | Jun. 30, 2024 | |
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS | ||
Issue price per unit | $ 10 | |
Gross proceeds | $ 160,000,000 | |
Proceeds from sale of Private Placements Warrants | $ 5,000,000 | |
Transaction costs | 10,184,856 | |
Underwriting fee | 3,000,000 | |
Deferred underwriting fee | 6,600,000 | |
Other offering costs | 584,856 | |
Percentage of ownership required to acquire in target company | 50% | |
Amount in trust account | $ 160,000,000 | $ 160,167,532 |
Period to complete the business combination | 24 months | |
Redemption percentage if business combination is not completed | 100% | |
Trust account price per share | $ 10 | |
Net interest to pay dissolution expenses | $ 100,000 | |
Minimum | ||
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS | ||
Threshold percent of fair market value of target businesses | 80% | |
Sponsor | ||
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS | ||
Trust account price per share | $ 10 | |
Public Warrants | ||
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS | ||
Number of warrants per unit | 0.5 | |
Private Placement Warrants | Sponsor | ||
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS | ||
Number of warrants sold | 5,000,000 | |
Issue price per warrant | $ 1 | |
Proceeds from sale of Private Placements Warrants | $ 5,000,000 | |
Class A ordinary share | ||
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS | ||
Number of shares per unit | 1 | |
Initial public offering | ||
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS | ||
Number of units sold | 16,000,000 | |
Issue price per unit | $ 10 | |
Underwriters over allotment Option | ||
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS | ||
Number of units sold | 1,000,000 |
SUMMARY OF SIGNIFICANT ACCOUN_4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) | Jun. 30, 2024 USD ($) |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | |
Cash | $ 1,037,126 |
Cash equivalents | $ 0 |
SUMMARY OF SIGNIFICANT ACCOUN_5
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Net Income per Ordinary Share (Details) - USD ($) | 3 Months Ended | 4 Months Ended |
Jun. 30, 2024 | Jun. 30, 2024 | |
Class A | ||
Net Loss per Ordinary Share | ||
Purchase of aggregate shares (in Shares) | 5,000,000 | |
Basic net income per ordinary share: | ||
Allocation of net income, basic | $ 26,666 | $ 18,633 |
Basic weighted average ordinary shares outstanding | 1,777,778 | 1,441,441 |
Basic net income per share (in dollars per share) | $ 0.01 | $ 0.01 |
Diluted net income per ordinary share: | ||
Allocation of net income, diluted | $ 25,540 | $ 18,087 |
Diluted weighted average ordinary shares outstanding | 1,777,778 | 1,441,441 |
Diluted net income per share (in dollars per share) | $ 0.01 | $ 0.01 |
Class B | ||
Basic net income per ordinary share: | ||
Allocation of net income, basic | $ 79,637 | $ 68,535 |
Basic weighted average ordinary shares outstanding | 5,309,309 | 5,301,923 |
Basic net income per share (in dollars per share) | $ 0.01 | $ 0.01 |
Diluted net income per ordinary share: | ||
Allocation of net income, diluted | $ 80,763 | $ 69,081 |
Diluted weighted average ordinary shares outstanding | 5,621,622 | 5,505,550 |
Diluted net income per share (in dollars per share) | $ 0.01 | $ 0.01 |
SUMMARY OF SIGNIFICANT ACCOUN_6
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Income Taxes, Concentration of Credit Risk (Details) | Jun. 30, 2024 USD ($) |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | |
Unrecognized tax benefits | $ 0 |
Amounts accrued for interest and penalties | 0 |
Federal depository insurance coverage | $ 250,000 |
SUMMARY OF SIGNIFICANT ACCOUN_7
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Class A Redeemable Share Classification (Details) | 4 Months Ended |
Jun. 30, 2024 USD ($) shares | |
Class A Redeemable Share Classification | |
Gross proceeds (in shares) | shares | 16,000,000 |
Temporary equity shares outstanding | shares | 16,000,000 |
Class A ordinary shares subject to redemption | |
Class A Redeemable Share Classification | |
Gross proceeds | $ 160,000,000 |
Proceeds allocated to Public Warrants | (2,080,000) |
Proceeds allocated to the over-allotment option | (169,119) |
Class A ordinary shares issuance costs | (10,024,214) |
Accretion of carrying value to redemption value | 12,440,865 |
Class A ordinary shares subject to possible redemption, 16,000,000 shares at redemption value of $10.01 per share | $ 160,167,532 |
PUBLIC OFFERING (Details)
PUBLIC OFFERING (Details) - $ / shares | Jun. 20, 2024 | Jun. 30, 2024 |
Public Warrants | ||
PUBLIC OFFERING | ||
Number of warrants in a unit | 0.5 | |
Class A ordinary share | ||
PUBLIC OFFERING | ||
Number of shares in a unit | 1 | |
Number of securities called by each warrant | 1 | |
Exercise price | $ 11.50 | |
Class A ordinary share | Public Warrants | ||
PUBLIC OFFERING | ||
Number of securities called by each warrant | 1 | |
Exercise price | $ 11.50 | |
Initial public offering | ||
PUBLIC OFFERING | ||
Number of units sold | 16,000,000 | |
Over allotment | ||
PUBLIC OFFERING | ||
Number of units sold | 1,000,000 | |
Issue price | $ 10 |
PUBLIC OFFERING - Warrants (Det
PUBLIC OFFERING - Warrants (Details) | 4 Months Ended | |
Jun. 30, 2024 D $ / shares shares | Jun. 20, 2024 $ / shares shares | |
PRIVATE PLACEMENT | ||
Warrants outstanding | 13,000,000 | |
Period over which warrants cannot be exercised | 30 days | |
Warrants expiry term | 5 years | |
Threshold period for filing registration statement after business combination | 20 days | |
Threshold business days for making the registration statement effective | D | 60 | |
Threshold trading days for fair market value calculation for cashless exercise of warrants | 60 days | |
Trading day prior to the date on which the notice of exercise is received | 10 days | |
Stock price trigger for redemption of warrants | $ / shares | $ 18 | |
Redemption price per warrant (in dollars per share) | $ / shares | $ 0.01 | |
Minimum threshold written notice period for redemption of warrants | 30 days | |
Redemption period | 20 days | |
Threshold trading days for redemption of warrants | 30 days | |
Threshold consecutive trading days for redemption of warrants | 30 days | |
Threshold consecutive trading days for redemption of warrants, commences | 3 days | |
Class A ordinary shares | ||
PRIVATE PLACEMENT | ||
Number of securities called by each warrant | 1 | |
Exercise price | $ / shares | $ 11.50 | |
Public Warrants | ||
PRIVATE PLACEMENT | ||
Warrants outstanding | 8,000,000 | |
Public Warrants | Class A ordinary shares | ||
PRIVATE PLACEMENT | ||
Number of securities called by each warrant | 1 | |
Exercise price | $ / shares | $ 11.50 | |
Private Warrants | ||
PRIVATE PLACEMENT | ||
Warrants outstanding | 5,000,000 |
PRIVATE PLACEMENT (Details)
PRIVATE PLACEMENT (Details) - USD ($) | Jun. 20, 2024 | Jun. 30, 2024 |
PRIVATE PLACEMENT | ||
Warrants expiry term | 5 years | |
Private Placement Warrants | ||
PRIVATE PLACEMENT | ||
Warrants issued (in shares) | 5,000,000 | |
Warrants issue price | $ 1 | |
Warrants issued | $ 5,000,000 | |
Number of securities called by each warrant | 1 | |
Exercise price | $ 11.50 | |
Threshold period for not to transfer, assign or sell any of their warrants after the completion of the initial business combination | 30 days | |
Warrants expiry term | 5 years | |
Redemption percentage of public shares if Business combination is not consummated | 100% |
RELATED PARTY TRANSACTIONS - Fo
RELATED PARTY TRANSACTIONS - Founder Shares (Details) - USD ($) | 1 Months Ended | ||
Mar. 11, 2024 | Mar. 31, 2024 | Jul. 24, 2024 | |
RELATED PARTY TRANSACTIONS | |||
Capital contribution from sponsor | $ 25,000 | ||
Class B ordinary shares | Sponsor | |||
RELATED PARTY TRANSACTIONS | |||
Number of shares issued (in shares) | 6,060,811 | ||
Class B ordinary shares | Subsequent event | |||
RELATED PARTY TRANSACTIONS | |||
Number of shares forfeited (in shares) | 439,189 | ||
Founder shares | Class A | |||
RELATED PARTY TRANSACTIONS | |||
Minimum Lock-up period (in years) | 1 year | ||
Stock price trigger (in $ per share) | $ 12 | ||
Threshold trading days (in days) | 20 days | ||
Threshold consecutive trading day period (in days) | 30 days | ||
Threshold Consecutive Trading Days Condition Commencement Days From Date of Initial Business Combination (in days) | 150 days | ||
Founder shares | Class B ordinary shares | Sponsor | |||
RELATED PARTY TRANSACTIONS | |||
Capital contribution from sponsor | $ 25,000 | ||
Capital contribution per share (in $ per share) | $ 0.004 | ||
Number of shares issued (in shares) | 6,060,811 | ||
Number of shares subject to forfeiture (in shares) | 790,541 | ||
Founder shares as percentage of issued and outstanding shares, if forfeiture is made (in %) | 26% | ||
Founder shares | Class B ordinary shares | Subsequent event | Sponsor | |||
RELATED PARTY TRANSACTIONS | |||
Number of shares forfeited (in shares) | 439,189 |
RELATED PARTY TRANSACTIONS - Pr
RELATED PARTY TRANSACTIONS - Promissory Notes (Details) - Promissory Note - Related Party - USD ($) | Jun. 20, 2024 | Jun. 30, 2024 |
RELATED PARTY TRANSACTIONS | ||
Aggregate loan amount as per agreement | $ 300,000 | |
Outstanding balance repaid | $ 249,389 | |
Excess amount repaid to the sponsor | $ 887 | |
Excess payment included in due to sponsor | $ 887 |
RELATED PARTY TRANSACTIONS - Ad
RELATED PARTY TRANSACTIONS - Administrative Services Agreement (Details) - Administrative Services Agreement | 4 Months Ended |
Jun. 30, 2024 USD ($) | |
RELATED PARTY TRANSACTIONS | |
Monthly expense payable | $ 10,000 |
Accrued for administrative services | 3,333 |
Expenses incurred for the period | $ 3,333 |
RELATED PARTY TRANSACTIONS - Re
RELATED PARTY TRANSACTIONS - Related Party Loans (Details) - Related Party Loans | Jun. 30, 2024 USD ($) $ / shares |
RELATED PARTY TRANSACTIONS | |
Maximum loan amount conversion | $ 1,500,000 |
Warrant conversion price ( in $ per share) | $ / shares | $ 1 |
Working capital loans outstanding | $ 0 |
COMMITMENTS (Details)
COMMITMENTS (Details) | 4 Months Ended | |
Jun. 20, 2024 shares | Jun. 30, 2024 USD ($) item $ / shares shares | |
COMMITMENTS | ||
Number of demands | item | 3 | |
Deferred underwriting fee | $ | $ 6,600,000 | |
Initial public offering | ||
COMMITMENTS | ||
Number of units issued upon exercise of option by underwriter | 16,000,000 | |
Underwriting discount per unit | $ / shares | $ 0.20 | |
Payments of underwriting discounts | $ | $ 3,000,000 | |
Deferred underwriting fee per unit excluding option | $ / shares | $ 0.40 | |
Over allotment | ||
COMMITMENTS | ||
Over-allotment period | 45 days | |
Maximum additional number of units offered to underwriters | 2,250,000 | |
Number of units issued upon exercise of option by underwriter | 1,000,000 | |
Number of units remaining for purchase under option | 1,250,000 | |
Deferred underwriting fee per unit relating to option | $ / shares | $ 0.60 |
STOCKHOLDERS' DEFICIT - Preferr
STOCKHOLDERS' DEFICIT - Preferred Shares (Details) | Jun. 30, 2024 $ / shares shares |
STOCKHOLDERS' DEFICIT | |
Preference shares, shares authorized | 5,000,000 |
Preference shares, par value (in dollars per share) | $ / shares | $ 0.0001 |
Preference shares, share issued | 0 |
Preference shares, share outstanding | 0 |
STOCKHOLDERS' DEFICIT - Ordinar
STOCKHOLDERS' DEFICIT - Ordinary Shares (Details) | 1 Months Ended | 4 Months Ended | ||
Mar. 11, 2024 USD ($) $ / shares shares | Mar. 31, 2024 USD ($) | Jun. 30, 2024 Vote $ / shares shares | Jul. 24, 2024 shares | |
STOCKHOLDERS' DEFICIT | ||||
Issuance of Class B ordinary shares to Sponsor | $ | $ 25,000 | |||
Number of cumulative votes per share | 0 | |||
Minimum | ||||
STOCKHOLDERS' DEFICIT | ||||
Percentage of affirmative votes for passing of special resolution in respect of business combination | 66.60% | |||
Percentage voted for appointment of directors | 50% | |||
Class A | ||||
STOCKHOLDERS' DEFICIT | ||||
Common shares, shares authorized | 500,000,000 | |||
Common shares, par value (in dollars per share) | $ / shares | $ 0.0001 | |||
Common shares shares issued | 0 | |||
Additional shares issuable, percentage | 26% | |||
Number of votes per share | Vote | 1 | |||
Class A ordinary shares subject to possible redemption | ||||
STOCKHOLDERS' DEFICIT | ||||
Common shares, shares outstanding | 16,000,000 | |||
Class B ordinary shares | ||||
STOCKHOLDERS' DEFICIT | ||||
Common shares, shares authorized | 50,000,000 | |||
Common shares, par value (in dollars per share) | $ / shares | $ 0.0001 | |||
Common shares shares issued | 6,060,811 | |||
Common shares, shares outstanding | 6,060,811 | |||
Maximum number of shares subject to forfeiture | 439,189 | |||
Number of votes per share | Vote | 1 | |||
Class B ordinary shares | Minimum | ||||
STOCKHOLDERS' DEFICIT | ||||
Percentage of affirmative votes for passing of special resolution | 90% | |||
Class B ordinary shares | Subsequent events | ||||
STOCKHOLDERS' DEFICIT | ||||
Common shares shares issued | 5,621,622 | |||
Common shares, shares outstanding | 5,621,622 | |||
Number of shares forfeited | 439,189 | |||
Class B ordinary shares | Sponsor | ||||
STOCKHOLDERS' DEFICIT | ||||
Issuance of Class B ordinary shares to Sponsor (in shares) | 6,060,811 | |||
Shares conversion ratio | 1 | |||
Class B ordinary shares | Sponsor | Founder shares | ||||
STOCKHOLDERS' DEFICIT | ||||
Issuance of Class B ordinary shares to Sponsor (in shares) | 6,060,811 | |||
Issuance of Class B ordinary shares to Sponsor | $ | $ 25,000 | |||
Issue price | $ / shares | $ 0.004 | |||
Maximum number of shares subject to forfeiture | 790,541 | |||
Founder shares as percentage of issued and outstanding shares, if forfeiture is made (in %) | 26% | |||
Shares conversion ratio | 26 | |||
Class B ordinary shares | Sponsor | Minimum | ||||
STOCKHOLDERS' DEFICIT | ||||
Shares conversion ratio | 1 | |||
Class B ordinary shares | Sponsor | Subsequent events | Founder shares | ||||
STOCKHOLDERS' DEFICIT | ||||
Number of shares forfeited | 439,189 |
FAIR VALUE MEASUREMENTS - Fair
FAIR VALUE MEASUREMENTS - Fair value of assets and liabilities (Details) | Jun. 30, 2024 USD ($) |
U.S. Treasury Securities | Level 1 | |
FAIR VALUE MEASUREMENTS | |
Assets - Fair value | $ 160,167,532 |
Over-allotment option liability | Level 3 | |
FAIR VALUE MEASUREMENTS | |
Liabilities - Fair value | $ 141,754 |
FAIR VALUE MEASUREMENTS - Measu
FAIR VALUE MEASUREMENTS - Measurement inputs for over-allotment option (Details) - Level 3 - Recurring | Jun. 30, 2024 Y $ / shares |
Risk-free interest rate | |
FAIR VALUE MEASUREMENTS | |
Over-allotment option measurement input | 0.0547 |
Expected term (years) | |
FAIR VALUE MEASUREMENTS | |
Over-allotment option measurement input | Y | 0.12 |
Expected volatility | |
FAIR VALUE MEASUREMENTS | |
Over-allotment option measurement input | 0.0542 |
Exercise price | |
FAIR VALUE MEASUREMENTS | |
Over-allotment option measurement input | 10 |
Fair value of over-allotment Unit | |
FAIR VALUE MEASUREMENTS | |
Over-allotment option measurement input | 10 |
FAIR VALUE MEASUREMENTS - Chang
FAIR VALUE MEASUREMENTS - Changes in fair value of level 3 financial instruments measured on recurring basis (Details) - Over-allotment option liability - Level 3 - Recurring | 4 Months Ended |
Jun. 30, 2024 USD ($) | |
Changes in fair value of level 3 liabilities measured on a recurring basis | |
Beginning Balance | $ 0 |
Initial measurement of over-allotment option liability | 141,754 |
Ending Balance | $ 141,754 |
FAIR VALUE MEASUREMENTS - Mea_2
FAIR VALUE MEASUREMENTS - Measurement inputs for public warrants (Details) - Level 3 - Recurring - Public Warrants | Jun. 20, 2024 Y $ / shares |
Asset price | |
FAIR VALUE MEASUREMENTS | |
Public warrants measurement input | $ / shares | 9.89 |
Term (years) | |
FAIR VALUE MEASUREMENTS | |
Public warrants measurement input | Y | 5.5 |
Risk-free interest rate | |
FAIR VALUE MEASUREMENTS | |
Public warrants measurement input | 0.043 |
Dividend yield | |
FAIR VALUE MEASUREMENTS | |
Public warrants measurement input | 0 |
Volatility | |
FAIR VALUE MEASUREMENTS | |
Public warrants measurement input | 0.040 |
Probability of closing | |
FAIR VALUE MEASUREMENTS | |
Public warrants measurement input | 0.300 |
SUBSEQUENT EVENTS (Details)
SUBSEQUENT EVENTS (Details) - Class B ordinary shares - shares | Jul. 24, 2024 | Jun. 30, 2024 |
SUBSEQUENT EVENTS | ||
Common shares shares issued | 6,060,811 | |
Common shares, shares outstanding | 6,060,811 | |
Subsequent events | ||
SUBSEQUENT EVENTS | ||
Number of shares forfeited | 439,189 | |
Common shares shares issued | 5,621,622 | |
Common shares, shares outstanding | 5,621,622 | |
Subsequent events | Sponsor | Founder shares | ||
SUBSEQUENT EVENTS | ||
Number of shares forfeited | 439,189 |